Funding Opportunities


The RIGHT Foundation’s Request for Proposals for two awards are now OPEN from
21 November 2022 through 25 January 2023, 10:00AM KST.


The RIGHT Foundation will also be hosting three online orientation sessions for RFP in early December.


[Session 1. English (7 Dec 2022 09:00-10:30 AM KST]
[Session 2. English (7 Dec 2022 04:00-05:30 PM KST]
[Session 3. Korean (8 Dec 2022 01:30-03:00 pm KST]


For more information and registration, please refer to the link below.

Product Development Award

Grants up to 4 billion KRW per project are available for projects that aim to develop vaccines, therapeutics, biologics or diagnostic platforms to alleviate infectious diseases with unmet health needs in Low- and Middle-Income Countries (LMICs). Funds requested should be commensurate with the activities outlined in the proposal. The project team must include at least one Korean entity. Collaborative submission between Korean and non-Korean institutions are highly encouraged.


Submit Link

Request for proposal
Request for proposal Instructions

Evidence Generation Award

Grants up to 200 million KRW per project are available for projects that aim to generate evidence on the current use and gaps in the application of digital health technologies in Global South. Funds requested should be commensurate with the activities outlined in the proposal. Collaborative submissions among multiple countries are highly welcome. The proposed project team must include at least one local institution based in the country or region that the evidence generation will focus on. Collaborative submission with a Korean entity is encouraged but not required.


Submit Link

Request for proposal
Request for proposal Instructions

Summary of Award Types

Product Development Award Evidence Generation Award
Target health conditions
  • Infectious diseases that disproportionately affect the people in the Low- and Middle-Income Countries (LMICs) or diseases with a pandemic potential
Development stage
  • From or near the initiation of the clinical development or validation phase to regulatory approval and WHO prequalification (WHO PQ).
Intervention types
  • Vaccines, therapeutics/biologics, diagnostics
Partnership requirement
  • Must include a Korean entity
  • Collaborative submission by multiple countries highly welcome and recommended
Award amount & duration
  • Up to 50%* of total project cost and up to 4 billion KRW/project for 3 years
  • To be commensurated with the proposed scope
Scope
  • Current use of and gaps in the application of digital platforms in infectious disease prevention/control or delivery of primary health care services in Low- and Middle-Income Countries (LMICs)
Intent
  • Assess the public health value of digital health technologies as global public good
  • Define problems to be solved with digital technologies that reflect the gaps and needs in LMICs
Partnership requirement
  • Collaboration with a Korean entity encouraged but not required
  • Must include local institutions from the countries that the proposed activities focus on
Award amount & duration
  • Up to 200 million KRW/project for 1 year
  • To be commensurated with the proposed scope

*Exceptions may apply

For inquiries, please visit our FAQ page or contact us to [email protected]